易特科(前海安测)“AI-CAD”院士研讨会

2019-06-18 17:01

2019年6月18日,易特科(前海安测)AI-CAD项目研讨会在易特科集团深圳总部、北京分部和西安研发中心联网召开。易特科集团董事长兼CEO张贯京先生主持召开本次会议。美国生物医学工程钱唯院士、郑斌院士和加拿大工程院姚育东院士、中国医科大学肿瘤专家赵明芳教授、海外归国博士马贺教授、齐守良教授在易特科集团(前海安测)深圳总部参会并发表专题报告。易特科集团副董事长肖应芬女士、CTO葛新科博士、联席总裁裴少荣博士、执行总裁兼COO罗文高先生、总工程师高伟明博士、副总工程师张红治博士、研究员唐苏明博士、研究员梁昊源博士、研究员陈琦博士等医学AI技术研发团队在深圳总部参会。


本次会议聚焦智能肺癌AI-CAD诊断、与癌症机理密切相关的医学影像、AI模型构建等主题。讨论会上,院士科学家团队探讨了AI-CAD肿瘤影像学领域的新理论、新知识、新技术,交流和展示了肿瘤影像学领域近年来取得的新进展,并分享了自己的最新研究成果和独到的心得体会,为大家带来了一场学术上的饕餮盛宴。




张贯京董事长指出,本次讨论聚焦肿瘤治疗的各学科前沿研究,探讨肿瘤救助的路径与可行方案,为今后易特科研发团队抓紧研发多模态肿瘤医疗影像智能分析及辅助诊断系统指明了方向,必将带动易特科集团新一轮医学影像研发的发展与变革。下一步,公司将围绕本次讨论会意见,进一步总结、分析、完善各项制度,确保以后的研发工作更有针对性、更具操作性。易特科集团将以不断进取的创新能力和优质的服务,在慢病管理、医学影像、肿瘤筛查等方面发挥积极作用,赢得更多未来!



院士科学家团队也充分肯定了易特科集团院士工作站的建设成效,同时对我司在智慧医疗领域取得的成绩表示赞赏,并表示将对集团学科建设和创新研发给予进一步的关注、支持和帮助,共同助力健康中国建设!



E-Techco (Qianhai AnyCheck) "AI-CAD" Academician Seminar

On June 18, 2019, E-Techco (Qianhai AnyCheck) AI-CAD project seminar was held in the network of E-Techco Group Shenzhen Headquarters, Beijing Branch and Xi'an R&D Center. Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group hosted this meeting. Academician Qian Wei of the American Biomedical Engineering, Academician Zheng Bin, Academician Yao Yudong of the Canadian Academy of Engineering, Professor Zhao Mingfang, an oncologist at China Medical University, Professor Ma He, and Dr. Qi Shouliang, overseas returning to the Shenzhen headquarters of E-Techco Group (Qianhai AnyCheck) will also publish a special report. Ms. Xiao Yingfen, Vice Chairman of E-Techco Group, Dr. Ge Xinke, CTO, Dr. Qi Shaorong, Co-President & COO Luo Wengao, Chief Engineer Dr. Gao Weiming, Deputy Chief Engineer Dr. Zhang Hongzhi, Researcher Dr. Tang Suming, Researcher Dr. Liang Haoyuan, Researcher Dr. Chen Qi The medical AI technology research and development team attended the meeting in Shenzhen.

The conference focused on the topic of intelligent lung cancer AI-CAD diagnosis, medical imaging and AI model construction closely related to cancer mechanism. At the seminar, the team of academicians and scientists discussed new theories, new knowledge and new technologies in the field of AI-CAD tumor imaging, exchanged and demonstrated new developments in the field of tumor imaging in recent years, and shared their latest research results.

Chairman Zhang Guanjing pointed out that this discussion focused on the frontier research of various disciplines of cancer treatment, explored the path and feasible solutions of cancer rescue, and pointed out the direction for the future research and development of E-Techco R&D team to grasp the multi-modal tumor medical image intelligent analysis and auxiliary diagnosis system. It will definitely drive the development and transformation of the new round of medical imaging research and development of E-Techco Group. In the next step, the company will further summarize, analyze and improve the various systems around the opinions of this seminar to ensure that the future research and development work is more targeted and more operational. E-Techco Group will play an active role in chronic disease management, medical imaging, tumor screening, etc. with continuous innovation and quality services to win more future.

The team of academician scientists also fully affirmed the effectiveness of the construction of E-Techco Group's academician workstations, and expressed appreciation for the achievements of our company in the field of smart medical treatment, and expressed that it will give further attention, support and help to the group's discipline construction and innovation research and development to build a healthy China.